PIKfyve 是一种含有 FYVE 指状结构的磷酸肌醇激酶,在人类中由 PIKFYVE 基因编码。PIKfyve 的主要酶活性是将 PtdIns3P 磷酸化为 PtdIns(3,5)P2。PIKfyve 活性负责 PtdIns(3,5)P2 和磷脂酰肌醇 5-磷酸 (PtdIns5P) 的产生。PIKfyve 是一种大型蛋白质,包含多个功能域并以多种剪接形式表达。通过直接结合膜 PtdIns(3)P,PIKfyve 的 FYVE 指状结构域对于将蛋白质定位到胞内体的胞质小叶至关重要。PIKfyve 酶活性因显性干扰突变体、siRNA 介导的消融或药物抑制而受损,导致内体增大和细胞质空泡化,这是由于 PtdIns(3,5)P2 合成受损所致。因此,通过 PtdIns(3,5)P2 的产生,PIKfyve 参与了内体动力学的多个方面,从而影响了从内体系统发出或穿过内体系统到达跨高尔基网络或沿内吞途径到达后续隔室的许多运输途径。
PIKfyve, a FYVE finger-containing phosphoinositide kinase, is an enzyme that in humans is encoded by the PIKFYVE gene. The principal enzymatic activity of PIKfyve is to phosphorylate PtdIns3P to PtdIns(3,5)P2. PIKfyve activity is responsible for the production of both PtdIns(3,5)P2 and phosphatidylinositol 5-phosphate (PtdIns5P). PIKfyve is a large protein, containing a number of functional domains and expressed in several spliced forms. By directly binding membrane PtdIns(3)P, the FYVE finger domain of PIKfyve is essential in localizing the protein to the cytosolic leaflet of endosomes. Impaired PIKfyve enzymatic activity by dominant-interfering mutants, siRNA- mediated ablation or pharmacological inhibition causes endosome enlargement and cytoplasmic vacuolation due to impaired PtdIns(3,5)P2 synthesis. Thus, via PtdIns(3,5)P2 production, PIKfyve participates in several aspects of endosome dynamics, thereby affecting a number of trafficking pathways that emanate from or traverse the endosomal system en route to the trans-Golgi network or later compartments along the endocytic pathway.
PIK5-12d 是一种 PROTAC PIKfyve 降解剂(DC50 = 1.48 nM),可在多种前列腺癌细胞中诱导大量细胞质液泡化并阻断自噬通量、抑制前列腺癌细胞增殖,并在携带 LTL-331R 人源前列腺癌 PDX 肿瘤的小鼠中显著抑制肿瘤增殖,因此可用于前列腺癌的研究(粉色:PIKfyve 配体 (MS-H14734);蓝色:VHL 配体 (MS-L68940);黑色:连接子)。
PIKfyve ligand-1 是一种 PIKfyve 配体,可用于合成诸如 PIK5-12d (MS-V23117) 等 PROTACs。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号